NCT02313116View on ClinicalTrials.gov

Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)

SuspendedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

February 29, 2020

Study Completion Date

March 18, 2020

Conditions
Breast Cancer
Interventions
DEVICE

Interferometric Synthetic Aperture Microscopy

Optical coherence tomography with interferometric synthetic aperture microscopy will be used to image ex vivo breast tissue specimens.

Trial Locations (1)

21231

Johns Hopkins Hospital, Baltimore

Sponsors
All Listed Sponsors
lead

Diagnostic Photonics, Inc.

INDUSTRY